Evidence map›Paper›PMID 38521521›Full record

ArticleBMJ open2024

Prostate Cancer Survivorship Essentials for men with prostate cancer on androgen deprivation therapy: protocol for a randomised controlled trial of a tele-based nurse-led survivorship care intervention (PCEssentials Hormone Therapy Study).

Anna Green, Robert U Newton, David P Smith, Haitham Tuffaha, Daniel A Galvão, Peter Heathcote, Manish I Patel, David Christie, Sam Egger, Sally Am Sara and 3 more

Open access · goldAbstract readClinical Trial Protocol
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 1 country.

Anna GreenCentre for Health Research, University of Southern Queensland, Springfield Central, Queensland, Australia Anna.Green@usq.edu.au.ORCID 0000-0002-7541-3665
Robert U NewtonExercise Medicine Research Institute, Edith Cowan University, Joondalup, Western Australia, Australia.ORCID 0000-0003-0302-6129
David P SmithThe Daffodil Centre, a joint venture with Cancer Council NSW, The University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0002-1474-3214
Haitham TuffahaThe University of Queensland, Saint Lucia, Queensland, Australia.ORCID 0000-0003-2993-3480
Daniel A GalvãoExercise Medicine Research Institute, Edith Cowan University, Joondalup, Western Australia, Australia.ORCID 0000-0002-8209-2281
Peter HeathcoteBrisbane Urology Clinic, Brisbane, Queensland, Australia.
Manish I PatelUniversity of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0003-1409-9171
David ChristieGenesiscare, Tugun, Queensland, Australia.ORCID 0000-0001-5494-8751
Sam EggerThe Daffodil Centre, a joint venture with Cancer Council NSW, The University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0003-1808-6909
Sally Am SaraProstate Cancer Foundation of Australia, St Leonards, New South Wales, Australia.ORCID 0000-0001-9268-5331
Nicole HenekaCentre for Health Research, University of Southern Queensland, Springfield Central, Queensland, Australia.ORCID 0000-0001-8102-1871
Suzanne K ChambersAustralian Catholic University, Brisbane, Queensland, Australia.ORCID 0000-0003-2369-6111
Jeff DunnCentre for Health Research, University of Southern Queensland, Springfield Central, Queensland, Australia.ORCID 0000-0002-1180-3381
The University of Sydney · AUEdith Cowan University · AUProstate Cancer Foundation of Australia · AUUniversity of Southern Queensland · AUAustralian Catholic University · AUBond University · AUQueensland Health · AUThe University of Queensland · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAndrogen deprivation therapy (ADT) is commonly used to treat men with locally advanced or metastatic prostate cancer. Men receiving ADT experience numerous side effects and frequently report unmet supportive care needs. An essential part of quality cancer care is survivorship care. To date, an optimal effective approach to survivorship care for men with prostate cancer on ADT has not been described. This protocol describes a randomised trial of tele-based nurse-led survivorship that addresses this knowledge gap: (1) determine the effectiveness of a nurse-led survivorship care intervention (PCEssentials), relative to usual care, for improving health-related quality of life (HR-QoL) in men with prostate cancer undergoing ADT and (2) evaluate PCEssentials implementation strategies and outcomes, including cost-effectiveness, compared with usual care. METHODS AND ANALYSIS: This is an effectiveness-implementation hybrid (type 1) trial with participants randomised to one of two arms: (1) minimally enhanced usual care and (2) nurse-led prostate cancer survivorship essentials (PCEssentials) delivered over four tele-based sessions, with a booster session 5 months after session 1. Eligible participants are Australian men with prostate cancer commencing ADT and expected to be on ADT for a minimum of 12 months. Participants are followed up at 3, 6 and 12 months postrecruitment. Primary outcomes are HR-QoL and self-efficacy. Secondary outcomes are psychological distress, insomnia, fatigue and physical activity. A concurrent process evaluation with participants and study stakeholders will be undertaken to determine effectiveness of delivery of PCEssentials. ETHICS AND DISSEMINATION: Ethics approval was obtained from the Metro South Health HREC (HREC/2021/QMS/79429). All participants are required to provide written informed consent. Outcomes of this trial will be published in peer-reviewed journals. The findings will be presented at conferences and meetings, local hospital departments, participating organisations/clinical services, and university seminars, and communicated at community and consumer-led forums. TRIAL REGISTRATION NUMBER: ACTRN12622000025730.

Indexed as

Cancer SurvivorsProstatic NeoplasmsAndrogen AntagonistsAndrogensAustraliaHumansMaleNurse's RoleProstateQuality of LifeRandomized Controlled Trials as TopicSurvivorshipAndrogen AntagonistsAndrogenshealth educationnursing Careprostatic neoplasmsquality of liferandomized controlled trial

Identifiers

PMID38521521
PMCPMC10961537
OpenAlexW4393120170

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.